journal article·2005-06

In vitro degradation of porous poly(propylene fumarate)/poly(dl-lactic-co-glycolic acid) composite scaffolds

Elizabeth L. Hedberg, Charles K. Shih, Jeremy J. Lemoine, Mark D. Timmer, Michael A. K. Liebschner, John A. Jansen, Antonios G. Mikos

Biomaterials· Volume 26· Issue 16
Publisher page

Abstract

This study investigated the in vitro degradation of porous poly(propylene fumarate) (PPF-based) composites incorporating microparticles of blends of poly(DL-lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) during a 26-week period in pH 7.4 phosphate-buffered saline at 37 degrees C. Using a fractional factorial design, four formulations of composite scaffolds were fabricated with varying PEG content of the microparticles, microparticle mass fraction of the composite material, and initial leachable porogen content of the scaffold formulations. PPF scaffolds without microparticles were fabricated with varying leachable porogen content for use as controls. The effects of including PLGA/PEG microparticles in PPF scaffolds and the influence of alterations in the composite formulation on scaffold mass, geometry, water absorption, mechanical properties and porosity were examined for cylindrical specimens with lengths of 13 mm and diameters of 6.5 mm. The composite scaffold composition affected the extent of loss of polymer mass, scaffold length, and diameter, with the greatest loss of polymer mass equal to 15+/-5% over 26 weeks. No formulation, however, exhibited any variation in compressive modulus or peak compressive strength over time. Additionally, sample porosity, as determined by both mercury porosimetry and micro-computed tomography did not change during the period of this study. These results demonstrate that microparticle carriers can be incorporated into PPF scaffolds for localized delivery of bioactive molecules without altering scaffold mechanical or structural properties up to 26 weeks in vitro.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (25)

Show source-provided references
1. Synthetic biodegradable polymers as orthopedic devices10.1016/S0142-9612(00)00101-0 ↗
2. Biodegradable polymer scaffolds to regenerate organs10.1007/3540587888_18 ↗
3. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
4. Biomaterial developments for bone tissue engineering10.1016/S0142-9612(00)00102-2 ↗
5. Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)-diacrylate macromers as crosslinking agents and characterization of their degradation products10.1016/S0032-3861(00)00479-1 ↗
6. In vitro cytotoxicity of injectable and biodegradable poly(propylene fumarate)-based networks10.1021/bm0300150 ↗
7. Bone formation in transforming growth factor beta-1 loaded porous poly(propylene fumarate) discs in cranial defects in rabbits10.1002/jbm.10073 ↗
8. Marrow stromal osteoblast function on a poly(propylene fumarate)/β−tricalcium phosphate biodegradable orthopaedic composite10.1016/S0142-9612(99)00254-9 ↗
9. Effects of transforming growth factor β1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate)10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.0.CO;2-0 ↗
10. Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model10.1002/jbm.1268 ↗
11. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites10.1016/S0168-3659(02)00261-4 ↗
12. Box · 1978
13. Montgomery · 2001
14. Evaluation of in vitro degradation of macroporous hydrogels using gravimetry, confined compression testing, and microcomputed tomography10.1021/bm020067+ ↗
15. Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate)
16. In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate10.1016/S0142-9612(02)00368-X ↗
17. New challenges in biomaterials
18. Why degradable polymers undergo surface or bulk erosion10.1016/S0142-9612(02)00170-9 ↗
19. Evaluation of thermal- and photo-crosslinked biodegradable poly(propylene fumarate)-based networks10.1002/jbm.a.10011 ↗
20. Biodegradation and biocompatibility of PLA and PLGA microspheres10.1016/S0169-409X(97)00048-3 ↗
21. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G ↗
22. Non-connected versus interconnected macroporosity in poly(2-hydroxyethyl methacrylate) polymers. An X-ray microtomographic and histomorphometric study10.1163/156856202320813828 ↗
23. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition10.1089/107632701753213183 ↗
24. Microarchitectual and mechanical characterization of oriented porous polymer scaffolds10.1016/S0142-9612(02)00361-7 ↗
25. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams10.1016/S0142-9612(00)00047-8 ↗